Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma

Do Young Kim,Moo-Kon Song,Joo Seop Chung,Ho-Jin Shin,Deok-Hwan Yang,Sung Nam Lim,Sung Yong Oh

Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma

2019

Do Young Kim
Moo-Kon Song
Joo Seop Chung
Ho-Jin Shin
Deok-Hwan Yang
Sung Nam Lim
Sung Yong Oh

Background Systemic inflammatory response can be associated with the prognosis of diffuse large B cell lymphoma (DLBCL). We investigated the systemic factors significantly related to clinical outcome in relapsed/refractory DLBCL.

Keywords:

Pathology
Refractory Diffuse Large B-Cell Lymphoma
Medicine
Internal medicine
in patient
Oncology
risk stratification
Lymphocyte
Diffuse large B-cell lymphoma
Multivariate analysis
Refractory
risk groups

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations